Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Renal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT03473730
What this trial is testing

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

Who this might be right for
Bladder Urothelial CarcinomaClear Cell Renal Cell CarcinomaMalignant Urinary System Neoplasm+2 more
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT00027820
What this trial is testing

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more
Fred Hutchinson Cancer Center 106
Testing effectiveness (Phase 2)Looking for participantsNCT07615348
What this trial is testing

CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Jinling Hospital, China 75
Very early researchActive Not RecruitingNCT02210117
What this trial is testing

Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage IV Renal Cell Cancer AJCC v7
M.D. Anderson Cancer Center 104
Testing effectiveness (Phase 2)Study completedNCT00057889
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer

Who this might be right for
Kidney Cancer
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Testing effectiveness (Phase 2)Looking for participantsNCT07551349
What this trial is testing

Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Beijing Biotech 36
Testing effectiveness (Phase 2)Study completedNCT00193258
What this trial is testing

Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
SCRI Development Innovations, LLC 94
Testing effectiveness (Phase 2)Study completedNCT00027573
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Alliance for Clinical Trials in Oncology 36
Testing effectiveness (Phase 2)Study completedNCT02915783
What this trial is testing

A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease

Who this might be right for
Non Clear Cell Renal Cell Carcinoma (nccRCC)
Eisai Inc. 41
Early research (Phase 1)Ended earlyNCT01943188
What this trial is testing

Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
Stanford University 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT06480565
What this trial is testing

A Phase 1/2 Trial of ADI-270 in ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Adicet Therapeutics 60
Early research (Phase 1)Study completedNCT00656734
What this trial is testing

Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.

Who this might be right for
Kidney Cancer
Bristol-Myers Squibb 27
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07218692
What this trial is testing

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+6 more
City of Hope Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00719264
What this trial is testing

Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer

Who this might be right for
CarcinomaAdenocarcinomaRenal Cell+2 more
Novartis Pharmaceuticals 365
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Ended earlyNCT03185182
What this trial is testing

Diagnostic Imaging for Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Region Skane 5
Early research (Phase 1)Looking for participantsNCT05433142
What this trial is testing

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Xencor, Inc. 307
Testing effectiveness (Phase 2)WithdrawnNCT03149159
What this trial is testing

Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Medical University of South Carolina
Next Page